ecteinascidin 743 has been researched along with taxane in 2 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (taxane) | Trials (taxane) | Recent Studies (post-2010) (taxane) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 1,288 | 210 | 779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, J; Colombo, N; Curigliano, G; D'Incalci, M; Dall'ó, E; De Braud, F; Gianni, L; Jimeno, J; Marsoni, S; Noberasco, C; Perotti, A; Sessa, C; Zanaboni, F | 1 |
| Anand, A; Giri, GV; Govind Babu, K; Jacob, LA; Koppaka, D; Kumar, RV; Lakshmaiah, KC; Lokanatha, D; Lokesh, KN; Rajeev, LK; Rudresha, AH; Saldanha, SC; Suresh Babu, MC | 1 |
1 trial(s) available for ecteinascidin 743 and taxane
| Article | Year |
|---|---|
Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails.
Topics: Adult; Aftercare; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cisplatin; Dioxoles; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Isoquinolines; Middle Aged; Ovarian Neoplasms; Salvage Therapy; Taxoids; Tetrahydroisoquinolines; Trabectedin; Treatment Failure | 2005 |
1 other study(ies) available for ecteinascidin 743 and taxane
| Article | Year |
|---|---|
Primary breast angiosarcoma - a single institution experience from a tertiary cancer center in South India.
Topics: Adult; Breast; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Dioxoles; Female; Hemangiosarcoma; Humans; India; Middle Aged; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Taxoids; Tertiary Care Centers; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2018 |